Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling
Authors
Keywords
-
Journal
Virology Journal
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-07
DOI
10.1186/s12985-020-01478-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Characteristics of COVID-19 infection in Beijing
- (2020) Sijia Tian et al. JOURNAL OF INFECTION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments
- (2020) Yashpal Singh Malik et al. VETERINARY QUARTERLY
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
- (2020) Balamurugan Shanmugaraj et al. Pathogens
- Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
- (2020) Hin Chu et al. CLINICAL INFECTIOUS DISEASES
- Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China
- (2020) Long Liu et al. Frontiers in Cellular and Infection Microbiology
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
- (2020) Yingxia Liu et al. National Science Review
- Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
- (2020) Ying Chi et al. JOURNAL OF INFECTIOUS DISEASES
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- The Chemokine System in Innate Immunity
- (2015) Caroline L. Sokol et al. Cold Spring Harbor Perspectives in Biology
- IP-10 in Autoimmune Thyroiditis
- (2014) I. Ruffilli et al. HORMONE AND METABOLIC RESEARCH
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
- (2014) Ali S Omrani et al. LANCET INFECTIOUS DISEASES
- Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response
- (2014) Hin Chu et al. VIROLOGY
- IFNβ autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages
- (2013) Michael J. Pattison et al. FEBS LETTERS
- A diverse range of gene products are effectors of the type I interferon antiviral response
- (2011) John W. Schoggins et al. NATURE
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients
- (2009) Say Li Kong et al. VIRUS RESEARCH
- Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence
- (2008) Juan C. Acosta et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More